Sentences with phrase «monkeys against the virus»

Not exact matches

Rhesus monkeys injected with the VLPs produced antibodies that gave them complete protection against the virus.

A molecule naturally produced by the immune system protects mice and monkeys against Zika virus infection, an international team of researchers has found.

Researchers for the past decade have focused on the T cell approach, based on studies showing that monkeys receiving such vaccines against simian immunodeficiency virus, related to HIV, lived longer or had lower viral levels than usual.

«Previously, we demonstrated that ZPIV protected mice and monkeys against Zika virus.»

-- Hyperimmune globulin, prepared by purifying and concentrating plasma of immunized animals or previously infected humans with high titers (concentrations) of neutralizing antibody against Ebola virus, which have been shown to be protective in monkeys but are not currently available and would not be expected before mid-2015.

Tests in macaque monkeys also showed that a single vaccine dose of only 50 micrograms provided strong protection against exposure to Zika virus five weeks later.

GOOD SHOT A test vaccine given to camels and monkeys gins up immunity against the MERS virus (shown here in a colorized micrograph).

Rhesus monkey TRIM5α protects against HIV - 1, but the only modern virus that the human protein has any effect on is one that causes leukemia in mice — which happens to be closely related to PtERV1.

One anticoagulant that Geisbert helped test against the virus was greeted with great enthusiasm when he presented results 7 years ago, because it was the first time a drug had much impact — and yet it only reduced deaths in monkeys by one - third.

In a previously published paper, Barouch and colleagues, including Colonel Nelson L. Michael, MD, PhD, director of the Military HIV Research Program at the Walter Reed Army Institute of Research (WRAIR) and Stephen Thomas, MD, Upstate Medical University, State University of New York, demonstrated that three different vaccine candidates provided robust protection against Zika virus in both mice and rhesus monkeys.

Infection researchers from the German Primate Center (DPZ)-- Leibniz Institute for Primate Research have in cooperation with international colleagues tested a new vaccination strategy against the HIV - related simian immunodeficiency virus (SIV) in rhesus monkeys.

A VACCINE against Zika virus has given mice and monkeys immunity in tests.

The investigators found that the immunized monkeys mounted antibody responses against diverse strains of HIV and the monkeys also mounted cellular immune responses to multiple regions of the virus.

An earlier preclinical study found that rhesus monkeys that were vaccinated with ZPIV developed a strong immune response and were protected against two strains of Zika virus.

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys.

2012 — Novel Ad26MVA vaccine provides protection against SIV — Results found Ad26 / MVA vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys.

Reporting in Nature Medicine this week, Philip Johnson, a professor of pediatrics at the University of Pennsylvania, in Philadelphia, and his colleagues managed to protect monkeys from infection with the simian immunodeficiency virus (SIV), the animal model that is closest to HIV, by shuttling a gene into their muscles that produces antibody - like molecules that work against SIV.

Results from a recent study show that novel vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys.

A research article published in the journal Science has reported the efficacy of three different vaccine platforms against the Zika virus in rhesus macaque monkeys.

So these data from monkeys, Dudley says, suggest «that a vaccine could be quite effective against the virus.»

The new Ad26 / MVA and Ad35 / Ad26 vector - based vaccine regimens resulted in over 80 % reduction in the per - exposure probability of acquisition of infection against repetitive challenges of SIV, a virus similar to HIV that infects monkeys.

When monkeys and apes are infected with Zika, they develop antibodies against the virus in approximately 14 days.